XML 28 R16.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Stock-Based Compensation
85 Months Ended
Sep. 30, 2010
Stock-Based Compensation
9. Stock-Based Compensation

The Company recognized stock-based compensation expense on all employee and non-employee awards as follows:

   
For the three months ended September 30,
   
For the nine months ended September 30,
 
                         
(in thousands)
 
2010
   
2009
   
2010
   
2009
 
                         
Research and development, including costs of research contracts
  $ 199     $ 140     $ 613     $ 295  
General and administrative
    824       375       2,585       969  
Stock-based employee compensation expense
  $ 1,023     $ 515     $ 3,198     $ 1,264  

The Company granted 42 thousand and 197 thousand stock options during the three and nine months ended September 30, 2010 that had a weighted-average grant date fair value of $2.66 and $3.42 per share, respectively.  During the nine months ended September 30, 2009, the Company granted 815 thousand stock options that had a weighted-average grant date fair value of $0.53 per share.  There were no stock options granted during the three month period ended September 30, 2009.
 
At September 30, 2010, there is $2.5 million stock compensation expense related to outstanding unvested stock options and restricted stock that will be expensed over a weighted average 23 months.

For the nine months ended September 30, 2010 and 2009, the fair value of stock options was estimated on the date of grant using a Black-Scholes option valuation model with the following assumptions:

   
For the nine months ended September 30,
 
   
2010
   
2009
 
             
Risk-free interest rate
   
1.28-2.75%
     
1.31-1.44%
 
Expected life in years
   
5
     
5
 
Expected volatility
   
89.2-90.6%
     
102-103%
 
Expected dividend yield
   
0
     
0
 

Stock option transactions under the Company’s stock option plan for the nine months ended September 30, 2010 are as follows:

(in thousands, except share and per share
data)
 
Number of
Shares
   
Weighted-
Average Exercise
Price
   
Weighted-
Average
Contractual
Term (Years)
   
Aggregate
Intrinsic Value
 
                         
Outstanding, December 31, 2009
    3,534,686     $ 2.82              
                             
Granted
    197,000       4.86              
Exercised
    196,167       1.19              
Cancelled
    6,667       5.19              
                             
Outstanding, September 30, 2010
    3,528,852     $ 3.02       6.88     $ 4,249,255  
                                 
Options exercisable, September 30, 2010
    2,568,019     $ 3.00       6.12     $ 3,375,200  
                                 
Options available for future grant
    3,074,734                          

A summary of the status of non-vested restricted stock for the nine months ended September 30, 2010 is as follows:

   
Number of Shares
   
Weighted-Average
Grant Date Fair Value
 
             
Non-vested, December 31, 2009
    1,467,167     $ 2.30  
Granted
    115,000     $ 5.15  
Vested
    1,052,583     $ 2.11  
Cancelled
    11,250     $ 4.34  
                 
Non-vested, September 30, 2010
    518,334     $ 3.29  

On June 23, 2010, the date of the Company’s annual stockholders meeting, the Company’s stockholders approved an amendment to the 2003 Stock Option Plan increasing the total shares reserved by 3,000,000 shares for a total of 9,002,436.